Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
More Concerns with the Massachusetts Millionaire’s Tax

More Concerns with the Massachusetts Millionaire’s Tax

Oct 11, 2022 | Op-Eds

Yesterday, the Wall Street Journal editorial board rightly noted multiple concerns with a November ballot initiative in Massachusetts that would amend the state constitution and establish a millionaire’s tax.

Massachusetts’s Proposed ‘Millionaires’ Tax’ Will Push up the Federal Deficit

Massachusetts’s Proposed ‘Millionaires’ Tax’ Will Push up the Federal Deficit

Apr 18, 2022 | Op-Eds

There is a proposed tax change in Massachusetts that should have all who are interested in fiscal policy concerned. In November, Bay State voters will decide whether to adopt an amendment to the state constitution imposing a 4 percent surtax on annual taxable income above $1 million starting in 2023.

  • Analysis (43)
  • Books (3)
  • Commentary (6)
  • Events (17)
  • Interviews (55)
  • News (54)
  • Op-Eds (84)
  • Press Releases (4)
  • Testimony (21)
  • Patent Thicket Remedies
    Patent Thicket RemediesDecember 7, 2023
  • US Tax Policy Israel-Hamas Conflict
    Don’t Mix US Tax Administration Policy with the Israel-Hamas ConflictNovember 2, 2023
  • Economics of Delinking PBM Compensation
    The Economics of “Delinking” PBM CompensationNovember 2, 2023
  • Leave the Tax Code Alone
    The Supreme Court Should Leave the Tax Code AloneOctober 24, 2023
  • Implications of Cannabis Legalization
    Implications of Cannabis Legalization for the US Federal BudgetOctober 24, 2023
  • Amicus Brief in Moore v. United States
    Amicus Brief in Moore v. United StatesOctober 24, 2023
  • Biosimilars Keys to Success
    Biosimilars – Keys to Success in the Pharmacy BenefitOctober 3, 2023
  • Regulatory Uncertainty for ESOPs
    New MGA White Paper Examines Consequences of Regulatory Uncertainty for Employee OwnershipOctober 2, 2023
  • PBMs in US Drug Pricing Debate
    MGA Releases White Paper on Role of PBMs in US Drug Pricing DebateSeptember 26, 2023
  • Unintended Consequences of Limiting PBMsSeptember 26, 2023
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact